Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Nichols

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Blood|December 25, 2015
Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVIIOscar A Marcos-Contreras, Shannon M Smith, Dwight A Bellinger, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 16, 2003
The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantationChristine L Lau, Edward Cantu, Gonzalo V Gonzalez-Stawinski, et al.
Ultrasound in Medicine & Biology|January 27, 2015
Non-invasive in vivo characterization of human carotid plaques with acoustic radiation force impulse ultrasound: comparison with histology after endarterectomyTomasz J Czernuszewicz, Jonathon W Homeister, Melissa C Caughey, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2024
Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor riskPooja Vir, Devi Gunasekera, Batsukh Dorjbal, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2026
Corrigendum to 'Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk' [Journal of Thrombosis and Haemostasis. Volume 22, Issue 12, December 2024, Pages 3415-3430]Pooja Vir, Devi Gunasekera, Batsukh Dorjbal, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape CapacityXiaolei Pei, Wenwei Shao, Allene Xing, et al.
Blood|April 4, 2002
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapyJane D Mount, Roland W Herzog, D Michael Tillson, et al.
Molecular Therapy. Methods & Clinical Development|August 25, 2018
An Observational Study from Long-Term AAV Re-administration in Two Hemophilia DogsJunjiang Sun, Wenwei Shao, Xiaojing Chen, et al.
JCI Insight|October 14, 2016
Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia modelsJoshua I Siner, Benjamin J Samelson-Jones, Julie M Crudele, et al.
Blood|January 9, 2010
Prolonged activity of factor IX as a monomeric Fc fusion proteinRobert T Peters, Susan C Low, George D Kamphaus, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Blood|December 25, 2015
Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVIIOscar A Marcos-Contreras, Shannon M Smith, Dwight A Bellinger, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 16, 2003
The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantationChristine L Lau, Edward Cantu, Gonzalo V Gonzalez-Stawinski, et al.
Ultrasound in Medicine & Biology|January 27, 2015
Non-invasive in vivo characterization of human carotid plaques with acoustic radiation force impulse ultrasound: comparison with histology after endarterectomyTomasz J Czernuszewicz, Jonathon W Homeister, Melissa C Caughey, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2024
Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor riskPooja Vir, Devi Gunasekera, Batsukh Dorjbal, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2026
Corrigendum to 'Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk' [Journal of Thrombosis and Haemostasis. Volume 22, Issue 12, December 2024, Pages 3415-3430]Pooja Vir, Devi Gunasekera, Batsukh Dorjbal, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape CapacityXiaolei Pei, Wenwei Shao, Allene Xing, et al.
Blood|April 4, 2002
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapyJane D Mount, Roland W Herzog, D Michael Tillson, et al.
Molecular Therapy. Methods & Clinical Development|August 25, 2018
An Observational Study from Long-Term AAV Re-administration in Two Hemophilia DogsJunjiang Sun, Wenwei Shao, Xiaojing Chen, et al.
JCI Insight|October 14, 2016
Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia modelsJoshua I Siner, Benjamin J Samelson-Jones, Julie M Crudele, et al.
Blood|January 9, 2010
Prolonged activity of factor IX as a monomeric Fc fusion proteinRobert T Peters, Susan C Low, George D Kamphaus, et al.
Pageof 11